Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 751 to 775 of 911

Sort by

Type: GuidanceRemove Type: Guidance filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Empagliflozin in combination therapy for treating type 2 diabetes	TA336	25 March 2015	25 March 2015
Rifaximin for preventing episodes of overt hepatic encephalopathy	TA337	25 March 2015	25 March 2015
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)	TA334	25 February 2015	25 February 2015
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	25 February 2015	25 February 2015
Sofosbuvir for treating chronic hepatitis C	TA330	25 February 2015	25 February 2015
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment	TA333	25 February 2015	25 February 2015
Eculizumab for treating atypical haemolytic uraemic syndrome	HST1	28 January 2015	28 January 2015
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma	TA269	12 December 2012	1 January 2015
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	TA327	17 December 2014	17 December 2014
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy	TA323	26 November 2014	26 November 2014
Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block	TA324	26 November 2014	26 November 2014
Nalmefene for reducing alcohol consumption in people with alcohol dependence	TA325	26 November 2014	26 November 2014
Imatinib for the adjuvant treatment of gastrointestinal stromal tumours	TA326	26 November 2014	26 November 2014
Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block	TA88	23 February 2005	1 November 2014
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation‑positive melanoma	TA321	22 October 2014	22 October 2014
Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis	TA320	27 August 2014	27 August 2014
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen	TA316	23 July 2014	23 July 2014
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes	TA317	23 July 2014	23 July 2014
Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma	TA319	23 July 2014	23 July 2014
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure	TA314	25 June 2014	25 June 2014
Canagliflozin in combination therapy for treating type 2 diabetes	TA315	25 June 2014	25 June 2014
Teriflunomide for treating relapsing–remitting multiple sclerosis	TA303	22 January 2014	1 June 2014
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	23 April 2014	23 April 2014
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation	TA311	23 April 2014	23 April 2014
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis	TA308	26 March 2014	26 March 2014

Results per page

10
25
50
All